NCT05844488View on ClinicalTrials.gov

DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

May 28, 2023

Study Completion Date

June 30, 2023

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

PrecivityAD

Measure risk for amyloid plaques in the brain and will include a test for certain genetic variants (specifically, ApoE proteins in the blood revealing APOE genotype) known to be associated with Alzheimer's disease.

Trial Locations (1)

46202

Indiana University Health Physicians Primary Care, Indianapolis

All Listed Sponsors
collaborator

Davos Alzheimer's Collaborative

UNKNOWN

collaborator

Regenstrief Institute, Inc.

OTHER

lead

Indiana University

OTHER